2017 UK Enteric Diseases Diagnostic Testing Market Future Horizons and Growth Strategies: Supplier Shares by Test, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities

March 2017 | 322 pages | ID: UED94234C86EN
Venture Planning Group

Abstracts

About This Report

This new 322-page report from VPGMarketResearch.com presents detailed analysis of the UK Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio and Yersinia. The report provides test volume and sales projections for Hospitals, Commercial and Public Health Labs.

In addition to market share and sales forecasts, the report:

• Examines market applications of Molecular Diagnostics,Monoclonal Antibodies, Immunoassays, IT and other emerging technologies;
• Reviews features and operating characteristics of major analyzers used for microbiology testing;
• Profiles key suppliers and potential market entrants developing innovativetechnologies and products;
• Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues.

Methodology

The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products.

In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as VPGMarketResearchs proprietary data files was conducted.

Contains 322 pages and 20 tables

Contents

I. INTRODUCTION

II. A1DS/H4 WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. Background
B. Diagnostic Tests: H4-1/2/Combo, H4Ag/H4 NAT, Western Blot, HTL5-1/2
C. 5accines and Drugs
D. 1nstrumentation Review and Market Needs
E. Emerging Diagnostic Technologies

III. UK: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS' Sales and Market Shares

IV. ALTERNATIVE MARKET PENETRATION STRATEGIES

A. 1nternal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
  1. MARKET1NG APPROACHES
  2. PRODUCT COMPLE11TY
  3. CUSTOMER PREFERENCE
  4. ESTABL1SHED SUPPL1ERS
  5. EMERG1NG SUPPL1ERS
  6. MAJOR TYPES OF D1STR1BUTORS
  7. MARKET SEGMENTAT1ON

V. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

VI. COMPETITIVE ASSESSMENTS

Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix/Erba
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Fujirebio
Grifols
Hologic/Gen-Probe
1D Biomedical/GSK
Kreatch/Leica
Lonza
Ortho-Clinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wallac/PE
Wako

L1ST OF TABLES

Table1. Major Companies Developing or Marketing A1DS Tests
Table 2. UK: H4 or H4-1/2/Combo Test 5olume and Sales Forecast by Market Segment
Table 3. UK: H4 Ag Test 5olume and Sales Forecast by Market Segment
Table 4. UK: Western Blot/Other Confirmatory Tests 5olume and Sales Forecast by Market Segment
Table 5. UK: H4 NAT Blood Screening Test 5olume and Diagnostics Sales
Table 6. UK: A1DS Diagnostics Market by Major Supplier
Table 7. UK: H4 Blood Screening NAT Sales and Market Shares of Major Suppliers